Alcon Inc. (ALC)
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. David J. Endicott
|
CEO & Director | 4.07M | -- | 1965 |
|
Mr. Timothy C. Stonesifer
|
Senior VP & CFO | -- | -- | 1967 |
|
Mr. Ian Bell
|
Senior VP & COO | -- | -- | 1971 |
|
Margaret Buckley
|
Chief Accounting Officer | -- | -- | -- |
|
Dr. Franck Leveiller Ph.D.
|
SVP of Global Research & Development and Chief Scientific Officer | -- | -- | -- |
|
Mr. Muru Murugappan
|
Senior VP and Chief Information & Transformation Officer | -- | -- | -- |
|
Mr. Daniel Cravens
|
Vice President of Investor Relations | -- | -- | -- |
|
Mr. Royce R. Bedward J.D.
|
Senior VP, General Counsel & Corporate Secretary | -- | -- | 1966 |
|
Ms. Kimberly Martin
|
Senior VP and Chief HR & Corporate Communications | -- | -- | 1975 |
|
Mr. Leon Sergio Duplan Fraustro
|
Senior VP & President of Americas | -- | -- | 1968 |
Alcon Inc.
- Sector:
- Healthcare
- Industry: Medical Instruments & Supplies
- Full Time Employees:
- 25,000
Description
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Corporate Governance
Upcoming Events
November 10, 2026 at 9:00 PM UTC
Alcon Inc. Earnings Date
Recent Events
May 15, 2026 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
May 7, 2026 at 12:00 AM UTC
Dividend Date
May 6, 2026 at 12:00 AM UTC
Ex-Dividend Date
